                               SEQUENCE LISTING

<110> BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
      STCUBE & CO., INC.
 
<120> ANTIBODIES AND MOLECULES THAT IMMUNOSPECIFICALLY BIND TO BTN1A1 
      AND THE THERAPEUTIC USES THEREOF

<130> 604556-228007

<140>
<141>

<150> 62/262,309
<151> 2015-12-02

<160> 55    

<170> PatentIn version 3.5

<210> 1
<211> 526
<212> PRT
<213> Homo sapiens

<400> 1
Met Ala Val Phe Pro Ser Ser Gly Leu Pro Arg Cys Leu Leu Thr Leu 
1               5                   10                  15      


Ile Leu Leu Gln Leu Pro Lys Leu Asp Ser Ala Pro Phe Asp Val Ile 
            20                  25                  30          


Gly Pro Pro Glu Pro Ile Leu Ala Val Val Gly Glu Asp Ala Lys Leu 
        35                  40                  45              


Pro Cys Arg Leu Ser Pro Asn Ala Ser Ala Glu His Leu Glu Leu Arg 
    50                  55                  60                  


Trp Phe Arg Lys Lys Val Ser Pro Ala Val Leu Val His Arg Asp Gly 
65                  70                  75                  80  


Arg Glu Gln Glu Ala Glu Gln Met Pro Glu Tyr Arg Gly Arg Ala Thr 
                85                  90                  95      


Leu Val Gln Asp Gly Ile Ala Lys Gly Arg Val Ala Leu Arg Ile Arg 
            100                 105                 110         


Gly Val Arg Val Ser Asp Asp Gly Glu Tyr Thr Cys Phe Phe Arg Glu 
        115                 120                 125             


Asp Gly Ser Tyr Glu Glu Ala Leu Val His Leu Lys Val Ala Ala Leu 
    130                 135                 140                 


Gly Ser Asp Pro His Ile Ser Met Gln Val Gln Glu Asn Gly Glu Ile 
145                 150                 155                 160 


Cys Leu Glu Cys Thr Ser Val Gly Trp Tyr Pro Glu Pro Gln Val Gln 
                165                 170                 175     


Trp Arg Thr Ser Lys Gly Glu Lys Phe Pro Ser Thr Ser Glu Ser Arg 
            180                 185                 190         


Asn Pro Asp Glu Glu Gly Leu Phe Thr Val Ala Ala Ser Val Ile Ile 
        195                 200                 205             


Arg Asp Thr Ser Ala Lys Asn Val Ser Cys Tyr Ile Gln Asn Leu Leu 
    210                 215                 220                 


Leu Gly Gln Glu Lys Lys Val Glu Ile Ser Ile Pro Ala Ser Ser Leu 
225                 230                 235                 240 


Pro Arg Leu Thr Pro Trp Ile Val Ala Val Ala Val Ile Leu Met Val 
                245                 250                 255     


Leu Gly Leu Leu Thr Ile Gly Ser Ile Phe Phe Thr Trp Arg Leu Tyr 
            260                 265                 270         


Asn Glu Arg Pro Arg Glu Arg Arg Asn Glu Phe Ser Ser Lys Glu Arg 
        275                 280                 285             


Leu Leu Glu Glu Leu Lys Trp Lys Lys Ala Thr Leu His Ala Val Asp 
    290                 295                 300                 


Val Thr Leu Asp Pro Asp Thr Ala His Pro His Leu Phe Leu Tyr Glu 
305                 310                 315                 320 


Asp Ser Lys Ser Val Arg Leu Glu Asp Ser Arg Gln Lys Leu Pro Glu 
                325                 330                 335     


Lys Thr Glu Arg Phe Asp Ser Trp Pro Cys Val Leu Gly Arg Glu Thr 
            340                 345                 350         


Phe Thr Ser Gly Arg His Tyr Trp Glu Val Glu Val Gly Asp Arg Thr 
        355                 360                 365             


Asp Trp Ala Ile Gly Val Cys Arg Glu Asn Val Met Lys Lys Gly Phe 
    370                 375                 380                 


Asp Pro Met Thr Pro Glu Asn Gly Phe Trp Ala Val Glu Leu Tyr Gly 
385                 390                 395                 400 


Asn Gly Tyr Trp Ala Leu Thr Pro Leu Arg Thr Pro Leu Pro Leu Ala 
                405                 410                 415     


Gly Pro Pro Arg Arg Val Gly Ile Phe Leu Asp Tyr Glu Ser Gly Asp 
            420                 425                 430         


Ile Ser Phe Tyr Asn Met Asn Asp Gly Ser Asp Ile Tyr Thr Phe Ser 
        435                 440                 445             


Asn Val Thr Phe Ser Gly Pro Leu Arg Pro Phe Phe Cys Leu Trp Ser 
    450                 455                 460                 


Ser Gly Lys Lys Pro Leu Thr Ile Cys Pro Ile Ala Asp Gly Pro Glu 
465                 470                 475                 480 


Arg Val Thr Val Ile Ala Asn Ala Gln Asp Leu Ser Lys Glu Ile Pro 
                485                 490                 495     


Leu Ser Pro Met Gly Glu Asp Ser Ala Pro Arg Asp Ala Asp Thr Leu 
            500                 505                 510         


His Ser Lys Leu Ile Pro Thr Gln Pro Ser Gln Gly Ala Pro 
        515                 520                 525     


<210> 2
<211> 1581
<212> DNA
<213> Homo sapiens

<400> 2
atggcagttt tcccaagctc cggtctcccc agatgtctgc tcaccctcat tctcctccag       60

ctgcccaaac tggattcagc tccctttgac gtgattggac ccccggagcc catcctggcc      120

gttgtgggtg aggacgccaa gctgccctgt cgcctgtctc cgaacgcgag cgccgagcac      180

ttggagctac gctggttccg aaagaaggtt tcgccggccg tgctggtgca tagggacggg      240

cgcgagcagg aagccgagca gatgcccgag taccgcgggc gggcgacgct ggtccaggac      300

ggcatcgcca aggggcgcgt ggccttgagg atccgtggcg tcagagtctc tgacgacggg      360

gagtacacgt gctttttcag ggaggatgga agctacgaag aagccctggt gcatctgaag      420

gtggctgctc tgggctctga ccctcacatc agtatgcaag ttcaagagaa tggagaaatc      480

tgtctggagt gcacctcagt gggatggtac ccagagcccc aggtgcagtg gagaacttcc      540

aagggagaga agtttccatc tacatcagag tccaggaatc ctgatgaaga aggtttgttc      600

actgtggctg cttcagtgat catcagagac acttctgcga aaaatgtgtc ctgctacatc      660

cagaatctcc ttcttggcca ggagaagaaa gtagaaatat ccataccagc ttcctccctc      720

ccaaggctga ctccctggat agtggctgtg gctgtcatcc tgatggttct aggacttctc      780

accattgggt ccatattttt cacttggaga ctatacaacg aaagacccag agagaggagg      840

aatgaattca gctctaaaga gagactcctg gaagaactca aatggaaaaa ggctaccttg      900

catgcagttg atgtgactct ggacccagac acagctcatc cccacctctt tctttatgag      960

gattcaaaat ctgttcgact ggaagattca cgtcagaaac tgcctgagaa aacagagaga     1020

tttgactcct ggccctgtgt gttgggccgt gagaccttca cctcaggaag gcattactgg     1080

gaggtggagg tgggagacag gactgactgg gcaatcggcg tgtgtaggga gaatgtgatg     1140

aagaaaggat ttgaccccat gactcctgag aatgggttct gggctgtaga gttgtatgga     1200

aatgggtact gggccctcac tcctctccgg acccctctcc cattggcagg gcccccacgc     1260

cgggttggga ttttcctaga ctatgaatca ggagacatct ccttctacaa catgaatgat     1320

ggatctgata tctatacttt ctccaatgtc actttctctg gccccctccg gcccttcttt     1380

tgcctatggt ctagcggtaa aaagcccctg accatctgcc caattgctga tgggcctgag     1440

agggtcacag tcattgctaa tgcccaggac ctttctaagg agatcccatt gtcccccatg     1500

ggggaggact ctgcccctag ggatgcagac actctccatt ctaagctaat ccctacccaa     1560

cccagccaag gggcacctta a                                               1581


<210> 3
<211> 125
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 3
Glu Val Gln Leu Gln Gln Ser Gly Pro Glu Leu Val Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Ile Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr His Tyr 
            20                  25                  30          


Asn Met Asp Trp Val Lys Gln Ser His Gly Lys Ser Leu Glu Trp Ile 
        35                  40                  45              


Gly Tyr Ile Tyr Pro Ser Asn Gly Gly Thr Gly Tyr Asn Gln Lys Phe 
    50                  55                  60                  


Lys Ser Arg Ala Thr Leu Thr Val Asp Lys Ser Ser Ser Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu His Ser Leu Thr Ser Glu Asp Ser Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Gly Ala Tyr His Tyr Gly Ser Ser Tyr Ala Tyr Trp Tyr Phe 
            100                 105                 110         


Asp Val Trp Gly Ala Gly Thr Thr Val Thr Val Ser Ser 
        115                 120                 125 


<210> 4
<211> 375
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polynucleotide"

<400> 4
gaggtccagc tgcagcagtc tggacctgag ctggtgaagc ctggggcttc agtgaagata       60

tcctgcaagg cttctggata cacattcact cactacaaca tggactgggt gaagcagagc      120

catggaaaga gccttgaatg gattggatat atttatcctt ccaatggtgg tactggctac      180

aaccagaaat tcaagagcag ggccacattg actgtagaca agtcctccag cacagcctac      240

atggaactcc acagcctgac atctgaggac tctgcagtct attactgtgc aagaggggcc      300

tatcactacg gtagttccta cgcctactgg tacttcgatg tctggggcgc agggaccacg      360

gtcaccgtct cctca                                                       375


<210> 5
<211> 109
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 5
Asp Ile Gln Met Thr Gln Thr Thr Ser Ser Leu Ser Ala Ser Leu Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Ser Cys Ser Ala Ser Gln Asp Ile Ser Asn Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Asp Glu Thr Val Lys Leu Leu Ile 
        35                  40                  45              


Ser Tyr Thr Ser Ser Leu His Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Tyr Ser Leu Thr Ile Ser Asn Leu Ala Pro 
65                  70                  75                  80  


Glu Asp Ile Ala Thr Tyr Tyr Cys Gln Gln Ser Ser Lys Leu Pro Phe 
                85                  90                  95      


Thr Phe Gly Ser Gly Thr Glu Leu Glu Ile Lys Arg Ala 
            100                 105                 


<210> 6
<211> 327
<212> DNA
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polynucleotide"

<400> 6
gatatccaga tgacacagac tacatcctcc ctgtctgcct ctctgggaga cagagtcacc       60

atcagttgca gtgcaagtca ggacattagc aattatttaa actggtatca gcagaaacca      120

gatgaaactg ttaaactcct gatctcttac acatcaagtt tacactcagg agtcccatca      180

agattcagtg gcagtgggtc tgggacagat tattctctca ccatcagcaa cctggcacct      240

gaagatattg ccacttacta ttgtcagcag tctagtaagc ttccattcac gttcggctcg      300

gggacagagt tggaaataaa acgggct                                          327


<210> 7
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 7
Gly Tyr Thr Phe Thr His Tyr 
1               5           


<210> 8
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 8
Tyr Pro Ser Asn Gly Gly 
1               5       


<210> 9
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 9
Gly Ala Tyr His Tyr Gly Ser Ser Tyr Ala Tyr Trp Tyr Phe Asp Val 
1               5                   10                  15      


<210> 10
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 10
Gly Tyr Thr Phe Thr His Tyr Asn Met Asp 
1               5                   10  


<210> 11
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 11
Tyr Ile Tyr Pro Ser Asn Gly Gly Thr Gly 
1               5                   10  


<210> 12
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 12
Gly Ala Tyr His Tyr Gly Ser Ser Tyr Ala Tyr Trp Tyr Phe Asp Val 
1               5                   10                  15      


<210> 13
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 13
His Tyr Asn Met Asp 
1               5   


<210> 14
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 14
Tyr Ile Tyr Pro Ser Asn Gly Gly Thr Gly Tyr Asn Gln Lys Phe Lys 
1               5                   10                  15      


Ser 
    


<210> 15
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 15
Gly Ala Tyr His Tyr Gly Ser Ser Tyr Ala Tyr Trp Tyr Phe Asp Val 
1               5                   10                  15      


<210> 16
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 16
Thr His Tyr Asn Met Asp 
1               5       


<210> 17
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 17
Trp Ile Gly Tyr Ile Tyr Pro Ser Asn Gly Gly Thr Gly 
1               5                   10              


<210> 18
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 18
Ala Arg Gly Ala Tyr His Tyr Gly Ser Ser Tyr Ala Tyr Trp Tyr Phe 
1               5                   10                  15      


Asp 
    


<210> 19
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 19
Ser Ala Ser Gln Asp Ile Ser Asn Tyr Leu Asn 
1               5                   10      


<210> 20
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 20
Tyr Thr Ser Ser Leu His Ser 
1               5           


<210> 21
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 21
Gln Gln Ser Ser Lys Leu Pro Phe Thr 
1               5                   


<210> 22
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 22
Ser Ala Ser Gln Asp Ile Ser Asn Tyr Leu Asn 
1               5                   10      


<210> 23
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 23
Tyr Thr Ser Ser Leu His Ser 
1               5           


<210> 24
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 24
Gln Gln Ser Ser Lys Leu Pro Phe Thr 
1               5                   


<210> 25
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 25
Ser Ala Ser Gln Asp Ile Ser Asn Tyr Leu Asn 
1               5                   10      


<210> 26
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 26
Tyr Thr Ser Ser Leu His Ser 
1               5           


<210> 27
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 27
Gln Gln Ser Ser Lys Leu Pro Phe Thr 
1               5                   


<210> 28
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 28
Ser Asn Tyr Leu Asn Trp Tyr 
1               5           


<210> 29
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 29
Leu Leu Ile Ser Tyr Thr Ser Ser Leu His 
1               5                   10  


<210> 30
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 30
Gln Gln Ser Ser Lys Leu Pro Phe 
1               5               


<210> 31
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 31
Arg Lys Lys Val Ser Pro Ala Val Leu 
1               5                   


<210> 32
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 32
Thr Val Ala Ala Ser Val Ile Ile Arg Asp Thr Ser Ala Lys Asn Val 
1               5                   10                  15      


Ser Cys Tyr 
            


<210> 33
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 33
Ile Arg Asp Thr Ser Ala Lys Asn 
1               5               


<210> 34
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 34
Leu Glu Leu Arg Trp Phe Arg Lys Lys Val Ser Pro Ala 
1               5                   10              


<210> 35
<211> 21
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 35
Glu Glu Gly Leu Phe Thr Val Ala Ala Ser Val Ile Ile Arg Asp Thr 
1               5                   10                  15      


Ser Ala Lys Asn Val 
            20      


<210> 36
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 36
Ala Thr Leu Val Gln Asp Gly Ile Ala Lys Gly Arg 
1               5                   10          


<210> 37
<211> 22
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 37
Asn Pro Asp Glu Glu Gly Leu Phe Thr Val Ala Ala Ser Val Ile Ile 
1               5                   10                  15      


Arg Asp Thr Ser Ala Lys 
            20          


<210> 38
<211> 19
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 38
Thr Val Ala Ala Ser Val Ile Ile Arg Asp Thr Ser Ala Lys Asn Val 
1               5                   10                  15      


Ser Cys Tyr 
            


<210> 39
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"


<220>
<221> MOD_RES
<222> (4)..(4)
<223> Any amino acid

<400> 39
Ala Glu Gln Xaa Pro Glu Tyr Arg Gly Arg Ala Thr 
1               5                   10          


<210> 40
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 40
Gly Arg Ala Thr Leu Val Gln Asp Gly Ile Ala Lys Gly Arg Val 
1               5                   10                  15  


<210> 41
<211> 21
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 41
Glu Glu Gly Leu Phe Thr Val Ala Ala Ser Val Ile Ile Arg Asp Thr 
1               5                   10                  15      


Ser Ala Lys Asn Val 
            20      


<210> 42
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 42
Tyr Cys Ala Arg Gly Ala Tyr 
1               5           


<210> 43
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 43
Thr Phe Thr His Tyr 
1               5   


<210> 44
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 44
Phe Thr Phe Gly Ser Gly Thr Glu 
1               5               


<210> 45
<211> 24
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 45
Ser Leu Glu Trp Ile Gly Tyr Ile Tyr Pro Ser Asn Gly Gly Thr Gly 
1               5                   10                  15      


Tyr Asn Gln Lys Phe Lys Ser Arg 
            20                  


<210> 46
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 46
Leu Leu Ile Ser Tyr Thr Ser Ser Leu His Ser Gly Val Pro Ser Arg 
1               5                   10                  15      


<210> 47
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 47
Thr Phe Thr His Tyr 
1               5   


<210> 48
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 48
Leu His Ser Gly Val Pro Ser Arg 
1               5               


<210> 49
<211> 10
<212> PRT
<213> Homo sapiens

<400> 49
Arg Leu Ser Pro Asn Ala Ser Ala Glu His 
1               5                   10  


<210> 50
<211> 10
<212> PRT
<213> Mus musculus

<400> 50
Gly Phe Ser Pro Asn Ala Ser Ser Glu Tyr 
1               5                   10  


<210> 51
<211> 10
<212> PRT
<213> Bos taurus

<400> 51
Arg Leu Ser Pro Asn Val Ser Ala Lys Gly 
1               5                   10  


<210> 52
<211> 10
<212> PRT
<213> Homo sapiens

<400> 52
Thr Ser Ala Lys Asn Val Ser Cys Tyr Ile 
1               5                   10  


<210> 53
<211> 10
<212> PRT
<213> Mus musculus

<400> 53
Ser Ser Ile Lys Asn Met Ser Cys Cys Ile 
1               5                   10  


<210> 54
<211> 10
<212> PRT
<213> Bos taurus

<400> 54
Ser Ser Met Lys Asn Val Ser Cys Cys Ile 
1               5                   10  


<210> 55
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      6xHis tag"

<400> 55
His His His His His His 
1               5       


